UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037215
Receipt number R000042431
Scientific Title Study of safety and efficacy of additional cryoablation after radiation therapy for malignant lung tumors
Date of disclosure of the study information 2019/06/30
Last modified on 2019/06/30 17:07:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Radioation therapy followed by cryoablation for malignant lung tumors

Acronym

Combined treatment by radiation therapy and cryoablation for malignant lung tumros

Scientific Title

Study of safety and efficacy of additional cryoablation after radiation therapy for malignant lung tumors

Scientific Title:Acronym

Combined treatment by radiation therapy and cryoablation for malignant lung tumros

Region

Japan


Condition

Condition

primary lung cancer, metastatic lung cancer

Classification by specialty

Pneumology Hematology and clinical oncology Chest surgery
Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The safety and efficacy of cryoablation after radiotherapy for malignant lung tumors larger than 2 cm in size are prospectively studied.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase II


Assessment

Primary outcomes

Side effect and local control rate by cryoablation after radiotherapy for malignant lung tumors

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Cryoablation is conducted after radiotherapy for malignant lung tumors larger than 2cm.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Malignant lung tumors larger than 1.8cm.

Key exclusion criteria

Patients who are not torelable for radiotherapy and cryoablation therapy.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Hiroaki
Middle name
Last name Nomori

Organization

Kashiwa Kousei General Hospital

Division name

Thoracic Surgery

Zip code

277-8551

Address

Shikoda 617, Kashiwa-city, Chiba

TEL

0471-45-1111

Email

hnomori@qk9.so-net.ne.jp


Public contact

Name of contact person

1st name Hiroaki
Middle name
Last name Nomori

Organization

Kashiwa Kousei General Hospital

Division name

Thoracic Surgery

Zip code

277-8551

Address

Shikoda 617, Kashiwa-city, Chiba

TEL

0471-45-1111

Homepage URL


Email

hnomori@qk9.so-net.ne.jp


Sponsor or person

Institute

Kashiwa Kousei General Hospital, Thoracic Surgery

Institute

Department

Personal name



Funding Source

Organization

Kashiwa Kousei General Hospital, Thoracic Surgery

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kashiwa Kousei General Hospital

Address

Shikoda 617, Kashiwa-city, Chiba

Tel

0471-45-1111

Email

hnomori@qk9.so-net.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 02 Month 15 Day

Date of IRB

2019 Year 02 Month 28 Day

Anticipated trial start date

2019 Year 06 Month 28 Day

Last follow-up date

2029 Year 07 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 06 Month 30 Day

Last modified on

2019 Year 06 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042431


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name